PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.\', \'Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/jmv.27542
?:hasPublicationType
?:journal
  • Journal of medical virology
is ?:pmid of
?:pmid
?:pmid
  • 34936121
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.978
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Bamlanivimab plus etesevimab treatment have a better outcome against COVID-19: A meta-analysis.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34936121>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34936121>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all